NCT05424952

Brief Summary

The primary objective of this study is to develop and evaluate a conversational AI service (chatbot) on social media platforms to obtain accurate and up-to-date vaccine information, and assess the impact of chatbot usage on users' vaccine confidence and acceptance in Hong Kong, Singapore, and Thailand.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2022

Geographic Reach
3 countries

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 21, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

February 11, 2022

Completed
4 months until next milestone

First Posted

Study publicly available on registry

June 21, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 17, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 17, 2023

Completed
Last Updated

December 6, 2024

Status Verified

December 1, 2024

Enrollment Period

1 year

First QC Date

December 21, 2021

Last Update Submit

December 3, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Covid-19 vaccines confidence Index

    1. "Overall, I think COVID-19 vaccines are important for children/senior parents (or grandparents)" 2. "Overall, I think COVID-19 vaccines are safe for children/parents (or grandparents)" 3. "Overall, I think COVID-19 vaccines are effective for children/parents (or grandparents)" The response is a 5-point Likert scale: (a) Strongly agree (b)Tend to agree (c) Do not know (d) Tend to disagree (e) Strongly disagree

    1 week

  • Covid-19 vaccines acceptance

    1. What is the vaccination status of your children/senior parents (or grandparents) as of now? 1. Is vaccinated with at least the first dose of the vaccine 2. Has made an appointment but has not been vaccinated with the first dose yet 3. Has not made an appointment but will get the vaccine. 4. Has no plan to get vaccinated anytime soon. 2. Do you want your children/senior parents (or grandparents) vaccinated against COVID-19 if vaccination is indicated and available for them? 1. Yes, definitely. 2. Unsure, but leaning towards yes. 3. Unsure, but leaning towards no. 4. No, definitely not.

    1 week

Study Arms (2)

Control

NO INTERVENTION

Eligible adults with unvaccinated senior parents/grandparents or children.

Intervention

EXPERIMENTAL

Eligible adults with unvaccinated senior parents/grandparents or children.

Other: Conversational AI Service (Chatbot)

Interventions

WhatsApp or Messenger Chatbot for COVID-19 vaccines

Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Hong Kong adult residents (English or Chinese users) with (a) unvaccinated senior parents/grandparents aged 60 (including those who received first dose after the announcement of the COVID passport on 4th of January) or (b) unvaccinated children aged below 18.
  • Thailand adult residents (Thai users) with (a) unvaccinated senior parents/grandparents aged 60 or above or (b) unvaccinated children aged below 18.
  • Singapore adult residents (English or Chinese users) with unvaccinated children aged between 5 to 11 years old.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

The University of Hong Kong

Hong Kong, Hong Kong

Location

National University of Singapore

Singapore, Singapore

Location

Health Intervention and Technology Assessment Program

Bangkok, Thailand

Location

Related Publications (18)

  • Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health. 1999 Sep;89(9):1322-7. doi: 10.2105/ajph.89.9.1322.

    PMID: 10474547BACKGROUND
  • Gaglio B, Shoup JA, Glasgow RE. The RE-AIM framework: a systematic review of use over time. Am J Public Health. 2013 Jun;103(6):e38-46. doi: 10.2105/AJPH.2013.301299. Epub 2013 Apr 18.

    PMID: 23597377BACKGROUND
  • Kobayashi T, Nishina Y, Tomoi H, et al. Corowa-kun: Impact of a COVID-19 vaccine information chatbot on vaccine hesitancy, Japan 2021. medRxiv 2021: 2021.05.26.21257854.

    BACKGROUND
  • de Figueiredo A, Simas C, Karafillakis E, Paterson P, Larson HJ. Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study. Lancet. 2020 Sep 26;396(10255):898-908. doi: 10.1016/S0140-6736(20)31558-0. Epub 2020 Sep 10.

    PMID: 32919524BACKGROUND
  • Larson HJ, Smith DM, Paterson P, Cumming M, Eckersberger E, Freifeld CC, Ghinai I, Jarrett C, Paushter L, Brownstein JS, Madoff LC. Measuring vaccine confidence: analysis of data obtained by a media surveillance system used to analyse public concerns about vaccines. Lancet Infect Dis. 2013 Jul;13(7):606-613. doi: 10.1016/S1473-3099(13)70108-7. Epub 2013 May 13.

    PMID: 23676442BACKGROUND
  • Wang Q, Yang L, Jin H, Lin L. Vaccination against COVID-19: A systematic review and meta-analysis of acceptability and its predictors. Prev Med. 2021 Sep;150:106694. doi: 10.1016/j.ypmed.2021.106694. Epub 2021 Jun 22.

    PMID: 34171345BACKGROUND
  • Zhang J, Featherstone JD, Calabrese C, Wojcieszak M. Effects of fact-checking social media vaccine misinformation on attitudes toward vaccines. Prev Med. 2021 Apr;145:106408. doi: 10.1016/j.ypmed.2020.106408. Epub 2021 Jan 1.

    PMID: 33388335BACKGROUND
  • Altay S, Hacquin AS, Chevallier C, Mercier H. Information delivered by a chatbot has a positive impact on COVID-19 vaccines attitudes and intentions. J Exp Psychol Appl. 2023 Mar;29(1):52-62. doi: 10.1037/xap0000400. Epub 2021 Oct 28.

    PMID: 34726454BACKGROUND
  • Thomala LL. Penetration rate of leading social networks in Hong Kong as of 3rd quarter 2020 (Link: https://www.statista.com/statistics/412500/hk-social-network-penetration/, last accessed on August 1, 2021). Statista; 2020.

    BACKGROUND
  • Kemp S. Digital 2021: Hong Kong (Link: https://datareportal.com/reports/digital-2021-hong-kong, last accessed on August 1, 2021). Data Reportal; 2021.

    BACKGROUND
  • Müller J. Social network penetration in Singapore Q3 2020 (Link: https://www.statista.com/statistics/284466/singapore-social-network-penetration/, last accessed on August 1, 2021). Statista; 2020.

    BACKGROUND
  • Huang C. Hong Kong faces uphill task to vaccinate its seniors against Covid-19 (Link: https://www.straitstimes.com/asia/east-asia/hong-kongs-uphill-push-to-vaccinate-its-seniors-against-covid-19, last accessed on August 1, 2021). The Straits Times. 2021.

    BACKGROUND
  • Steve. Lexicon. The LINE Phenomenon in Thailand - By the Numbers (Link: https://lexiconthai.com/blog/the-line-phenomenon-in-thailand-by-the-numbers/, last accessed on August 1, 2021), 2020.

    BACKGROUND
  • Agency T. Line in Thailand Internet Population (Link: https://www.twfdigital.com/blog/2020/04/line-user- stat-in-thailand-2020/, last accessed on August 1, 2021), 2020.

    BACKGROUND
  • Get bad news (Link: https://www.getbadnews.com/#intro, last accessed on August 1, 2021). 2021.

    BACKGROUND
  • Elkin J. WHO launches a chatbot on Facebook Messenger to combat COVID-19 misinformation. (Link: https://www.who.int/news-room/feature-stories/detail/who-launches-a-chatbot-powered-facebook- messenger-to-combat-covid-19-misinformation, last accessed: August 1, 2021). 2020.

    BACKGROUND
  • Larson HJ, Schulz WS, Tucker JD, Smith DM. Measuring vaccine confidence: introducing a global vaccine confidence index. PLoS Curr. 2015 Feb 25;7:ecurrents.outbreaks.ce0f6177bc97332602a8e3fe7d7f7cc4. doi: 10.1371/currents.outbreaks.ce0f6177bc97332602a8e3fe7d7f7cc4.

    PMID: 25789200BACKGROUND
  • SAGE. Report of the SAGE Working Group on Vaccine Hesitancy (Link: https://www.who.int/immunization/sage/meetings/2014/october/1_Report_WORKING_GROUP_vaccine_hesita ncy_final.pdf, last accessed on August 1, 2021), 2014.

    BACKGROUND

MeSH Terms

Conditions

Vaccination Hesitancy

Condition Hierarchy (Ancestors)

Vaccination RefusalTreatment RefusalTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Joseph T Wu, PhD

    The University of Hong Kong

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 21, 2021

First Posted

June 21, 2022

Study Start

February 11, 2022

Primary Completion

February 17, 2023

Study Completion

February 17, 2023

Last Updated

December 6, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will share

Individual participant data that underlie the results reported in the article, after de-identification (text, tables, figures, and appendices), will be shared. A written data-sharing request for meta-analysis should be submitted by email with a methodologically sound proposal. Proposals should be directed to kathysleung@connect.hku.hk; to gain access, data requestors will need to sign a data access agreement.

Shared Documents
STUDY PROTOCOL
Time Frame
Beginning 9 months and ending 36 months following article publication
Access Criteria
Researchers who provide a methodologically sound proposal for meta-analysis. Proposals should be directed to Kathyleung@connect.hku.hk; to gain access, data requestors will need to sign a data access agreement.

Locations